SIGA · Siga Technologies Inc · Executive Compensation
$3.12
-0.03 (-0.95%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$226.33M
Shares
71.85M
Volume · Oct 21
267.55K
Avg daily vol (3M)
715.38K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Diem Nguyen | Chief Executive Officer and Director | $3,244,492 |
| Daniel J. Luckshire | Executive Vice President and Chief Financial Officer | $1,567,217 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,559,428 |
| Larry Miller | General Counsel and Corporate Secretary | $1,538,982 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Diem Nguyen | Ph.D. MBA Chief Executive Officer | $4,449,790 |
| Larry Miller | General Counsel & Secretary | $2,188,014 |
| Daniel J. Luckshire | Executive Vice President, & Chief Financial Officer | $1,460,684 |
| Dennis E. Hruby | Executive Vice President & Chief Scientific Officer | $1,453,450 |
| Jay K. Varma | Former Executive Vice President & Chief Medical Officer (employment ended September 2024) | $548,295 |
| Phillip L. Gomez | Former Chief Executive Officer (retired in January 2024) | $138,527 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | Former Chief Executive Officer (retired in January 2024) | $1,825,856 |
| Dennis E. Hruby | Executive Vice President & Chief Scientific Officer | $1,811,114 |
| Daniel J. Luckshire | Executive Vice President, & Chief Financial Officer | $1,718,140 |
| Jay K. Varma | Former Executive Vice President & Chief Medical Officer (employment ended September 2024) | $670,534 |
| Larry Miller | General Counsel & Secretary | — |
| Diem Nguyen | Ph.D. MBA Chief Executive Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | Former Chief Executive Officer (retired in January 2024) | $1,738,912 |
| Dennis E. Hruby | Executive Vice President & Chief Scientific Officer | $1,411,116 |
| Daniel J. Luckshire | Executive Vice President, & Chief Financial Officer | $1,384,375 |
| Robin E. Abrams | Former General Counsel and Chief Administrative Officer | $186,121 |
| Jay K. Varma | Former Executive Vice President & Chief Medical Officer (employment ended September 2024) | — |
| Diem Nguyen | Ph.D. MBA Chief Executive Officer | — |
| Larry Miller | General Counsel & Secretary | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | Chief Executive Officer | $1,688,264 |
| Daniel J. Luckshire | Executive Vice President, & Chief Financial Officer | $1,311,272 |
| Dennis E. Hruby | Executive Vice President & Chief Scientific Officer | $1,304,776 |
| Robin E. Abrams | Former General Counsel and Chief Administrative Officer | $1,239,088 |
| Jay K. Varma | Executive Vice President & Chief Medical Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | Chief Executive Officer | $1,639,090 |
| Dennis E. Hruby | Executive Vice President & Chief Scientific Officer | $1,466,772 |
| Daniel J. Luckshire | Executive Vice President, & Chief Financial Officer | $1,273,080 |
| Robin E. Abrams | Former General Counsel and Chief Administrative Officer | $1,102,998 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Daniel J. Luckshire | Executive Vice President & Chief Financial Officer | $1,684,000 |
| Phillip L. Gomez | Chief Executive Officer | $1,591,350 |
| Robin E. Abrams | General Counsel and Chief Administrative Officer | $1,518,872 |
| Dennis E. Hruby | Vice President & Chief Scientific Officer | $1,429,876 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | Ph.D. Chief Executive Officer | $1,545,000 |
| Daniel J. Luckshire | Executive Vice President & Chief Financial Officer | $1,200,000 |
| Dennis E. Hruby | Vice President & Chief Scientific Officer | $1,194,054 |
| Robin E. Abrams | General Counsel and Chief Administrative Officer | $1,159,382 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | Chief Executive Officer | $1,662,329 |
| Dennis E. Hruby | Vice President & Chief Scientific Officer | $1,247,276 |
| Daniel J. Luckshire | Executive Vice President & Chief Financial Officer | $1,043,348 |
| Robin E. Abrams | General Counsel and Chief Administrative Officer | $1,009,400 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| General John M. “Jack” Keane (Ret.) | director | Appointed | 2025-03-18 |
| Dr. Jay Varma | Board of Directors | Terminated | 2024-09-23 |
| Dr. Jay Varma | Executive Vice President and Chief Medical Officer | Terminated | 2024-09-23 |
| Phil Gomez | CEO | Retired | 2024-01-22 |
| Diem Nguyen | Board of Directors | Appointed | 2024-01-22 |
| Phillip Louis Gomez, III | Chief Executive Officer | Retired | 2024-01-22 |
| Diem Nguyen | member of the Company's Board of Directors | Appointed | 2024-01-22 |
| Diem Nguyen | Chief Executive Officer | Appointed | 2024-01-22 |
| Dr. Jay K. Varma | Executive Vice President and Chief Medical Officer | Appointed | 2023-09-06 |
| Jay Varma, MD | director | Appointed | 2022-11-14 |
| Harold Ford | director | Appointed | 2022-11-14 |
| James Antal | Board of Directors | Resigned | 2022-08-04 |
Leadership
- Diem Nguyen CEO, Board Member
- Diem Nguyen, Ph.D., MBA CEO, Board Member
- Daniel J. Luckshire CFO
- Larry Miller General Counsel
- Edward P. Taibi Board Member
- Gary J. Nabel Board Member
- General John M. “Jack” Keane (Ret.) Board Member
- Harold E. Ford Board Member
- Harold E. Ford, Jr Board Member
- Harold Ford Board Member
- Holly L. Phillips Board Member
- Jay Varma Board Member
- Jay Varma, MD Board Member
- Jaymie A. Durnan Board Member
- John M. "Jack" Keane Board Member
- Joseph W. Marshall Board Member
- Joseph W. Marshall, III Board Member
- Julian Nemirovsky Board Member
Key facts
CIK
1010086
CUSIP
826917106
13F (30d)
19 filings
19 filers
Visit website
Investor relations